chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 26 year old female with penicillin allergy and sulfonamide allergy and a history of fainting after getting her ears pierced who on 23-JUN-2009 was vaccinated IM with the first 0.5 mL dose of GARDASIL (lot # 658271/0558X). There was no concomitant medication. The patient felt light-headed a few minutes after receiving her first dose of GARDASIL. The patient rested and was monitored in the office. She subsequently recovered fully. Additional information is not expected.
Night received vaccine, arm swollen size of tennis ball. Within 48 hours, shortness of breath, aching, became worse. Client asthmatic, so used Advair Inhaler. Saw allergist 12/30/02; said bronchial tubes still swollen.
Patient received Pfizer COVID vaccine on 2/23/21 (lot # EL3302), 3/16/21 (lot # EN6200), 8/18/21 (lot # FC3182), and 7/13/22 (lot # FM0173). Patient tested positive for COVID on 7/29/22 and 8/4/22. On 8/4/22, patient admitted with acute respiratory failure with hypoxia and COVID pneumonia. Patient was intubated on 8/7/22. As of today (8/9/22), patient is still intubated.
Headache, Rash, and low grade fever . Pharmacy called me on 9/21 to let me know that they accidentally administered the Pfizer Adult booster instead of the 3 dose of the toddler vaccine.
Left side of face numb tingling and spasms.  Left eye hard to focus and spasm around the eye.
No reaction. Upon research today we found that the vaccine expired on 2/28/2022 from the manufacturer. It wasn't discarded properly and was administered to the patient on 3/3/2022. Will this be ok, should we reach out to the patient. Was curious if there was any data on the above lot#  that shows the vaccine was still effective. Thank You
Chills, fever, muscle aches, headache, fatigue, muscle weakness, dizziness
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: patient got both shots and complaint of dizziness i told him to keeping seating while a call 911. The paramentics came in started cpr and took the patient away to the hospital
Low grade fever, sore arm, swollen arm, red area around and above injection site cough, burning eyes, sore throat, dry cough.
Fever, chills, extreme tiredness. Sore, red, swollen, itchy arm at injection site. That began 2 days after injection. Hypersensitive ?Covid Arm?.
Presented to ED with palpitations, found to be in rapid ventricular response, likely due to symptomatic COVID-19 infection; tx w/O2, steroids, singulair, zinc; weaned to RA; dc'd to HHC.
DIZZINESS; HEAVINESS IN THE HEAD; NECK PAIN; TEMPORARY DISCOMFORT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case No concomitant medications were reported. On an unspecified date, the subject experienced dizziness, heaviness in the head, neck pain, and temporary discomfort. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizziness, heaviness in the head, neck pain and temporary discomfort was not reported. This report was non-serious.
Started with extreme arm pain, headache day of injection. The following morning (approx. 23 hours after vaccination) injection site felt warm to touch and swelling. Spot feels hard. A red rash has started. 10 hours later, still warm to touch, swelled and rash has increased in size
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), TACHYCARDIA (Fast heartbeat), PYREXIA (Fever of 103.9), NAUSEA (Nausea) and VOMITING (Vomiting) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02612OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced DIZZINESS (Dizziness), TACHYCARDIA (Fast heartbeat), PYREXIA (Fever of 103.9), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness), TACHYCARDIA (Fast heartbeat), PYREXIA (Fever of 103.9), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103.9 (High) 103.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
headache for 2 days then resolved, restless leg syndrome for 3 days then resolved, yellow oily diarrhea on day 4 with no change to diet
Pt noticed soreness and redness on arms starting the evening of 8/2 that is still present.  Pt presented in the clinic this morning for allergy injection and pt had redness in both upper extremities (worse on right side) with heat and swelling (mild but noticedable) noted.  Pt did not recieve allergy injection today.
Extreme fatigue and brain fog.  Abnormal labs showed on 12/16/2021 that I had decreased GFR to 56 and increased Creatine.  On 1/24/222, my labs were checked again the GFR was at 59 and Creatine was still increased. I was referred for a renal ultrasound.
Headache, Myalgia, NauseaVomiting, light sensitivity, pain both shoulders & back of head, appetite loss, right hand pain & left ankle pain, fatigue Narrative:  Other Relevant History:
HYPOXIA 4/4/2023 ABNL ABDOMINAL IMAGING HYPOXIA 4/4/2023 DM 2 W RENAL MANIFESTATION HYPOXIA 4/4/2023 UTI (URINARY TRACT INFECTION)
Missed menstrual cycle, usually have a 26 day cycle, has been 60 days.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient missed menstrual cycle (usually has a 26-day cycle, has been 60 days). The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event missed menstrual cycle, usually have a 26-day cycle, has been 60 days was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fainted. Felt faint, sat in chair,  fainted, woke up on floor with chair tipped over. Nauseated, dizzy, & stiff muscles for several hours.
Approximately 24 hours following injection pt developed erythema, warmth, itchy and swelling to LUE approximately 5 x 2 in dimension. No drainage. No tenderness & no other sx.
Symptoms: Numbness, Pain. Service Member received AVA, typhoid and Smallpox vaccines on 3/23/06. She believes she received 1 or 2 vaccines in her right deltoid, but is not sure if it was smallpox, typhoid or both vaccines. She knows she received her first anthrax vaccine in her left deltoid area. She denies any unusual burning during or immediately following receipt of the anthrax vaccine. She denies any unusual redness, swelling or induration at or surrounding the anthrax vaccine site. (She recalls redness and swelling about the size of a nickel surrounding the anthrax vaccine site. She also recalls a subcutaneous nodule < the size of a pea.) She does not recall experiencing any systemic symptoms like fever, chills, headaches, fatigue or arthralgias within the first week of vaccine receipt. Almost immediately after vaccine receipt, SM noted aching pain ("like after receipt of thyroid vaccine", just in area of vaccine receipt), but by mid-afternoon she experienced an intensified pain that affected her whole arm. This pain was accompanied by numbness. The pain is described as muscle pain - "like after working out for too long" and the numbness is described like the sensation after receipt of lidocaine by the dentist. Her arm movement and functioning were limited both by pain and the inability to really feel what her hand was doing. SM was out-processing for deployment so she did not seek evaluation or a profile. The pain was rated as 6/10 using a pain scale of 0 (=no pain) to 10 (=worst pain ever experienced). She took ibuprofen which slightly diminished the pain (deceased to level 4-5/10) but did not resolve. The pain and numb sensation lasted approximately 3-4 days before completely resolving. On 12 April 2006, SM received her 2nd anthrax vaccine in her left deltoid region and experienced a very similar reaction. She experienced muscle pain and numbness within hours of vaccine receipt that lasted about 3-4 days before completely resolving. Otherwise, she denies any unusual or prolonged local or systemic symptoms following receipt of her second anthrax vaccine. She has had no recurrence of symptoms since April 2006. She has received a typhoid vaccine in her left deltoid without experiencing unusual pain and/or numbness of that extremity.
DEVELOPED TIGHTNESS IN THROAT THAT LASTED APPROXIMATELY 15 MINUTES.
Pt recvd 2nd dose of vax on 27NOV90 & on 8DEC90 pt devel inflamed rt sinus & the next day pt exp chills, & flushing; By 12DEC90 pt condition worsened & pt exp fatigue; Seen by MD dx sinusitis; fever 101.3, body aches, malaise, weakness etc;
No adverse event; administered a dose of the monovalent vacccine which was past beyond 30 day use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose of the monovalent vacccine which was past beyond 30 day use date) and NO ADVERSE EVENT (No adverse event) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 05-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose of the monovalent vacccine which was past beyond 30 day use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered a dose of the monovalent vacccine which was past beyond 30 day use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered a dose of the monovalent vacccine which was past beyond 30 day use date).    Concomitant medications details were not reported by the reporter.  It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Reportedly, Vial was initially placed on the refrigerator on 24-Oct-2022 and the vaccine was administered on 05-Nov-2022.  Treatment details were not reported by the reporter.
May 9  have not had a period since December 2020 and was always two days May 10  YES Headache Fatigue or tiredness Nausea &   feet cramp and no longer get periods since before 2021 and have had twice blood flow :(.  Nausea and tiredness have kept me from being able to do my usual workout or other activities. NO Redness/Swelling Muscle pain/Pain Chills/ Fever
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2021 as dose 2, single (Lot number: EW0153) at the age of 33 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 18Nov2021 as dose 3 (booster), single (Lot number: 066F21A), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Vaccine brand: Pfizer / BioNTech,, Vaccine lot number: EP7534,, DOSE 1, SINGLE, Vaccine location: Left arm), administration date: 17Mar2021, for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: Patient received treatment with Paxlovid from 25May2022.  No follow-up attempts are possible. No further information is expected.
joint pain; muscle pain; injection arm soreness; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (injection arm soreness), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, WARFARIN and LISINOPRIL for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (injection arm soreness). On 22-Apr-2021, the patient experienced ARTHRALGIA (joint pain) and MYALGIA (muscle pain). On 18-Apr-2021, VACCINATION SITE PAIN (injection arm soreness) had not resolved. At the time of the report, ARTHRALGIA (joint pain) and MYALGIA (muscle pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
TINGLING IN ARMS AND HANDS BILATERALLY FOR 5 MINUTES DIRECTLY AFTER VACCINES WERE ADMINISTERED.  THEN, C/O "SHAKING ON THE INSIDE" ONLY IN LT ARM AND HAND FOR ABOUT 5 MORE MINUTES. BENADRYL 12.5MG GIVEN PO ABOUT 5 MINUTES AFTER ADMINISTRATION OF VACCCINES. MONITORED CLIENT FOR 30 MINUTES WHILE IN CLINIC. EDUCATED MOTHER AND CLIENT ON SIDE EFFECTS AND ADVERSE REACTIONS TO ALL 3 VACCINES AND WHEN TO SEEK FURTHER MEDICAL CARE BEFORE CLIENT LEFT CLINIC. VERBALIZED UNDERSTANDING.
Pt recvd 2 doses of Hep B vax on 5AUG91 & 6SEP91 respectively; On 8OCT91 pt devel high fever; In middle of October pt exp fatigue; 21OCT91 h/a, swollen lymph nodes; 28OCT91 presented to MD; also exp dec appetite & diarrhea;
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 27-MAR-2017(conflicting information), the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 27-JAN-2014 (conflicting information), the patient was treated by a physician for the onset of a blistery rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. On or about 27-JAN-2017 (conflicting information), the patient was also treated for shingles that spread into her eyes, also called herpes zoster keratitis. The patient has been prescribed acyclovir and methylprednisolone (MEDROL packs) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Upon internal review the event of herpes zoster keratitis was determined to be medically significant. Additional information has been requested.
She says it seems like the right hand does not know what the left hand is doing.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot no and expiry date not reported) via an unspecified route of administration on 28Jan2021 for covid-19 immunisation. The patient medical history, concomitant medications and past drug history were not reported. It was reported that caller was calling about Pfizer COVID 19 vaccine. She had her first shot on 28Jan, and she was then scheduled to get second dose on 19Feb which was Friday and the weather forecast predicting heavy snow and ice on Friday and she did not see any way that she was going to be able to get from her house to (Hospital name withheld) for the appointment. What did she need to do? Who did she contact to reschedule that appointment? She said the people contacted her for the appointment. On an unknown date, she said it seems like the right hand did not know what the left hand was doing. She was not calling to report an adverse events or product complaints. She said she would go back and call someone else. She said she did not have anything to say other than this had been a horrible experience, she had been on the phone for an hour and a half and was trying to find out who to contact to change the appointment and no one could help her with it, it was totally unacceptable. The outcome of event was unknown.  Information about lot/batch number has been requested.   Follow-up attempts are completed. No further information is expected.
A non-serious report of INFLUENZA and decreased effectiveness of LAIV was received from literature concerning cases of influenza amongst recruits vaccinated with LAIV. No past medical history or concomitant medication were provided for the patients. On an unknown date the patients received FLUMIST. Approximately 10, 000 recruits were vaccinated and 69 recruits were confirmed to have contracted influenza in the southeast region of the country. It was reported that cases of influenza among military recruits mirrored that in the surrounding civilian population and CDC data concluded that an antigenic draft was circulating in the area which was responsible for the breakthrough cases H1N1 and that there was no issue with the LAIV. The outcome of the event influenza were not reported.
terrible headache; body aches; muscle aches; she couldn't get up; muscles gave up; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team.  A female patient received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MOBILITY DECREASED (non-serious), outcome "recovered", described as "she couldn't get up"; MUSCLE DISORDER (non-serious), outcome "recovered", described as "muscles gave up"; HEADACHE (non-serious), outcome "recovered", described as "terrible headache"; PAIN (non-serious), outcome "not recovered", described as "body aches"; MYALGIA (non-serious), outcome "not recovered", described as "muscle aches". Additional information: Reporter is the patient's sister. Patient couldn't get up after she got the vaccine. Her muscles gave up. That happened for a day. She had a terrible headache that lasted 3 or 4 days. Her body aches are still there. It's been over a month since she got the vaccine. Until now, she still has muscle aches, body aches.  The lot number for BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021411277 Same reporter/drug, different patient, similar events
Shortly after receiving the SHINGRIX vaccine, patient experienced pain in her arm when she lifted it and moved it in a certain way. It does not hurt 24/7. She went to Dr on 4/5/2018 and 7/5/2018 to check her arm pain. She went to Dr (chiropractor) on 4/25/2018 and 5/6/2018 6/12/2018 and 6/29/2018 since she wanted relief from her arm pain. She also sees the chiropractor for her back issues.
Exactly 1 week after the shot my arm started to itch near the injection site and over the next few days a rash has appeared.
Inflammation bladder (No medication). Drank water to help with baking soda it relives the acidity.
Pt. received 1st dose of Moderna on 12/28/20 and on 01/06/21.  Pt. was evaluated by ARNP and Dr. will follow up
Cellulitis R arm, and warmth and tenderness and edema.  On 2/16/10: Rx: SEPTRA 3tsp BID X 10 d Rx: prednisone 40mg 2 daily x 5 d2/17/10 2/19/10 Improved cellulitis some residual edema.
Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild